. Author manuscript; available in PMC: 2012 Dec 1.

Published in final edited form as: J Subst Abuse Treat. 2011 Aug 9;41(4):415–421. doi: 10.1016/j.jsat.2011.06.008

Table 3.

Logistic regressions for re-enrollment in any treatment and methadone treatment (n = 97)

Dependent measure	Variable	Adjusted OR¹ (95% CI¹)	p-value
Re-enrollment in any treatment modality	Treatment modality-first episode²	1.85 (0.73-4.69)	0.374
	Days in treatment-first episode³	1.41 (0.54-3.65)	0.976
	Attendance to treatment re-engagement group⁴	2.57 (0.96-6.88)	0.088
Re-enrollment in methadone treatment	Treatment modality-first episode²	1.52 (0.49-4.69)	0.771
	Days in treatment-first episode³	1.13 (0.35-3.62)	0.659
	Attendance to treatment re-engagement group⁴	5.51 (1.92-15.83)	0.001

OR: Odds Ratio; CI: Confidence Interval

Methadone versus other treatment modality

≤ 60 days versus > 60 days

⁴

Any attendance versus no attendance